POLYMORPHIC METABOLISM OF MEPHENYTOIN IN MAN - PHARMACOKINETIC INTERACTION WITH A CO-REGULATED SUBSTRATE, MEPHOBARBITAL

被引：63
作者：
JACQZ, E
HALL, SD
BRANCH, RA
WILKINSON, GR
机构：
[1] VANDERBILT UNIV,MED CTR,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1986年 / 39卷 / 06期
关键词：
D O I：
10.1038/clpt.1986.113
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：646 / 653
页数：8
相关论文
共 30 条
[1]   PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE [J].
BERTILSSON, L ;
DENGLER, HJ ;
EICHELBAUM, M ;
SCHULZ, HU .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) :153-155
[2]  
BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[3]   CRITICAL EVALUATION OF THE POTENTIAL ERROR IN PHARMACOKINETIC STUDIES OF USING THE LINEAR TRAPEZOIDAL RULE METHOD FOR THE CALCULATION OF THE AREA UNDER THE PLASMA LEVEL TIME CURVE [J].
CHIOU, WL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (06) :539-546
[4]   EVIDENCE FOR AN ENZYMATIC DEFECT IN THE 4-HYDROXYLATION OF DEBRISOQUINE BY HUMAN-LIVER [J].
DAVIES, DS ;
KAHN, GC ;
MURRAY, S ;
BRODIE, MJ ;
BOOBIS, AR .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (01) :89-91
[5]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
[6]   DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].
EICHELBAUM, M ;
SPANNBRUCKER, N ;
STEINCKE, B ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187
[7]  
EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[8]  
HALL SD, 1985, FED PROC, V44, P1257
[9]  
IDLE JR, 1984, 2ND P WORLD C CLIN P, P148
[10]   MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS [J].
INABA, T ;
JURIMA, M ;
NAKANO, M ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :670-676
123